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ABSTRACT
Friedreich’s ataxia (FRDA) is caused by biallelic ex-
pansion of GAA repeats leading to the transcription-
al silencing of the frataxin (FXN) gene. The exact
molecular mechanism of inhibition of FXN expres-
sion is unclear. Herein, we analyze the effects of
hyperexpanded GAA repeats on transcription status
and chromatin modifications proximal and distal to
the GAA repeats. Using chromatin immunopre-
cipitation and quantitative PCR we detected signifi-
cant changes in the chromatin landscape in FRDA
cells relative to control cells downstream of the pro-
moter, especially in the vicinity of the GAA tract. In
this region, hyperexpanded GAAs induced a particu-
lar constellation of histone modifications typically
associated with heterochromatin-like structures.
Similar epigenetic changes were observed in GFP
reporter construct containing 560 GAA repeats.
Furthermore, we observed similar levels of FXN
pre-mRNA at a region upstream of hyperexpanded
GAA repeats in FRDA and control cells, indicating
similar efficiency of transcription initiation. We also
demonstrated that histone modifications associated
with hyperexpanded GAA repeats are independent
of initiation and progression of transcription. Our
data provide strong evidence that FXN deficiency in
FRDA patients results from a block of transition
from initiation to a productive elongation of FXN
transcription due to heterochromatin-like struc-
tures formed in the proximity of the hyperexpanded
GAAs.
INTRODUCTION
Friedreich’s ataxia (FRDA) is an inherited degenerative
disease that is characterized by progressive ataxia, inclu-
ding uncoordinated gait and limb movements, weakened
muscle strength, and diminished senses of position and
vibration. FRDA is caused by an insufﬁcient level of
Frataxin (FXN) (1,2). FXN is an evolutionarily conserved
mitochondrial protein that is involved in iron homeostasis
in cells (3). Reduced levels of the FXN gene expression in
FRDA patients are caused by a hyperexpanded tract of
repeated GAA triplets in intron 1 of the FXN gene (4,5).
In FRDA patients, the GAA tract frequently consists
of >1000 triplets, whereas unaffected individuals have 66
or fewer repeats at the FXN gene (4). Pathological expan-
sion of the GAA repeats is associated with localized chro-
matin changes and transcriptional silencing at the gene;
however, the underlying molecular mechanisms of
hyperexpanded GAA-induced transcriptional defects are
not yet clear.
The hyperexpanded GAA repeats at the FXN gene have
been reported to adopt a heterochromatin-like structure
that is characterized by high levels of di- and tri-
methylated lysine 9 of histone H3 (H3K9me2/3) and un-
deracetylated H3 and H4 (6–9). Inhibitors of histone
deacetylases increase levels of FXN expression in FRDA
primary lymphocytes and in a murine model (8,10).
Additionally, altering histone modiﬁcations, especially levels
of acetylation, can partially reactivate expression of the FXN
gene. Thus, the results of these studies suggest that changes
in chromatin structure upstream of the hyperexpanded
GAA repeats induce FXN silencing. However, it is not
clear whether the heterochromatin-like structure induced
by the hyperexpanded tract of GAA repeats impacts
initiation and/or elongation of FXN transcription.
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formation induced by the hyperexpanded GAA repeats
extend to the promoter region and affect initiation of
FXN transcription (11,12). Repressive marks such as
H3K27me3 and H3K9me3, as well as heterochromatin
protein (HP1) are enriched at the transcription start site
(TSS) of the FXN gene in FRDA ﬁbroblast lines, which
results in the failure of FXN transcription initiation. These
heterochromatin marks may also affect expression of anti-
sense transcripts at the region upstream of the FXN TSS,
thereby interfering with initiation of FXN sense transcripts
in FRDA patients (11). Other studies suggest that FXN
deﬁciency results not only from defective initiation, but
also transcript elongation (12). Levels of both H3K4me3
at the TSS (represents active transcription initiation) of
the FXN gene and H3K36me3 (an indicator of transcrip-
tion elongation) are decreased at the FXN gene in FRDA
cell lines.
Epigenetic changes induced by the hyperexpanded
GAA repeats are one of the primary therapeutic targets
in FRDA. A number of studies have demonstrated that
speciﬁc histone deacetylase inhibitors (HDACi) are
capable of enhancing histone acetylation and FXN expres-
sion in FRDA cells (8–10). On the contrary, a repressive
mark, H3K9me3, observed in the proximity of the long
GAA repeats is sustained during HDACi treatment (8,10).
Additionally, inhibition of H3K9 methylation with BIX-
01294 has no effect on FXN expression in FRDA cells
(17). These results suggest that simultaneous targeting of
two or more epigenetic silencing pathways may be required
to restore full activity of the FXN gene. Therefore, a
detailed deﬁnition of the landscape of histone modiﬁca-
tions associated with hyperexpanded GAA repeats is ne-
cessary in order to further understand the molecular
mechanisms underlying chromatin changes in FRDA
cells and their relationship to FXN deﬁciency.
While previous studies have examined selected histone
modiﬁcations at the FXN gene, each study was limited in
either the scope of the modiﬁcations examined or the
number of cell lines analyzed. Here we report a compre-
hensive analysis of histone modiﬁcation patterns in mul-
tiple lymphoid cell lines derived from FRDA patients and
unaffected controls. We found that the hyperexpanded
GAA repeats affect chromatin structure in the proximity
of the GAA repeats, but do not extend to the promoter. In
contrast, the distribution of RNA pol II and histone
methylation marks associated with transcription elong-
ation were underrepresented in the presence of the
hyperexpanded GAA repeats at the FXN gene in FRDA
cell lines. These results strongly support the hypothesis
that the transcription machinery correctly initiates synthe-
sis of the FXN mRNA. Interestingly, RNA pol II is
enriched and appears to be paused at the FXN
promoter-proximal region in unaffected cell lines, but
not FRDA cells. We also found that altered enrichment
of H3K4me3 and H3K79me2 at the FXN gene reﬂects
defective transcription at a post-initiation step. Taken
together, our study provides strong evidence that FXN
deﬁciency in FRDA patients results from a block in the
transition between initiation and elongation of FXN tran-
scription. This deﬁciency is possibly attributed to
heterochromatin-like structures formed in the proximity
of the hyperexpanded GAAs that act as an obstacle to
the elongation of FXN pre-mRNA.
MATERIALS AND METHODS
Cell lines
Lymphoid cell lines were purchased from NIGMS Human
Genetic Cell Repository at The Coriell Institute for
Medical Research, Camden, NJ, USA. We selected three
cell lines derived from FRDA patients: GM15850 harbor-
ing two expanded alleles of approximately 650 and 1030
GAA repeats; GM16798 harboring two expanded alleles
of approximately 750 and 1000 GAA repeats and
GM16209 harboring approximately 800 GAA repeats on
both alleles of the FXN gene. As controls we also used
three lymphoid cell lines (GM15851, GM03928 and
GM05152) derived from healthy, unaffected individuals
containing short GAA repeat tracts within a normal
range. Lymphoid cell lines were grown in RPMI 1640
medium supplemented with 15% FBS, 100U/ml penicillin
and 100mg/ml streptomycin at 37 Ci n5 %C O 2. The
GFP_GAA systems [GFP_(GAA·TTC)0 and GFP_
(GAA·TTC)560] were generated by integration of a tract
of GAA repeats derived from the GM16210 affected cells
as described previously (9). A DNA fragment harboring
approximately 560 GAA repeats was PCR ampliﬁed from
genomic DNA isolated from the GM16210 cell line
(NIGMS Human Genetic Cell Repository at The Coriell
Institute for Medical Research, Camden, NJ, USA) as
described in (9). PCR product was cleaved by Bsu36I
and BssHII endonucleases and the GAA repeat-
containing fragment was cloned into intron 1 (1.2kb
from the exon1/intron1 junction) of the GFP gene of the
pGFP_Int plasmid (13,14). Plasmids containing 0 and 560
GAA repeats were integrated by site-speciﬁc recombin-
ation into the genome of the HEK293Flp-InT-Rex cell
line (Invitrogen). The use of identical sites of integration
for both GFP_(GAA·TTC)0 and GFP_(GAA·TTC)560
constructs allows direct comparison between cell lines
and eliminates any potential bias resulting from random
integration events in different chromosomal contexts.
Integrants were selected using hygromycin (200mg/ml); in-
dividual hygromycin-resistant colonies were isolated and
analyzed for repeat size and GFP expression level. Correct
splicing of the GFP mRNA was determined as described
earlier (4). All constructs were sequenced prior to as well
as after establishing the stable cell lines. The GFP_GAA
lines were selectively maintained in Dulbecco’s ModiEed
Eagle’s Medium with 10% FBS, 100U/ml penicillin and
100mg/ml streptomycin at 37 Ci n5 %C O 2 supplemented
with hygromycin (200mg/ml) and blasticidin (5mg/ml). To
induce transcription of the GFP minigene in the
GFP_GAA system, cells were treated with 0.1mg/ml tetra-
cycline for 24h.
Polymerase chain reaction
The size of the hyperexpanded tract of GAA repeats in
lymphoid cell lines were determined by conventional PCR
using primers 2500F and 629 under previously described
Nucleic Acids Research, 2011,Vol.39, No. 19 8367conditions (4). The insertion of the GAA repeats at an
intron of the GFP gene in the GFP_GAA system was
detected by the conventional PCR using the primers
listed in Table 1. The PCR products were analyzed on
0.8% agarose gels.
To perform quantitative reverse transcriptase–PCR
(qRT–PCR), total RNAs from lymphoid cell lines and
the GFP_GAA system were isolated using the RNeasy
Mini Kit (Qiagen). DNase I (TURBO DNA-free;
Ambion) was added to remove genomic DNA contamin-
ation from isolated RNAs. The qRT–PCR was conducted
using the Power SYBR Green RNA-to-CT 1-Step Kit
(7500 Fast Real Time–PCR System, Applied
Biosystems). As a control, reactions were also performed
without reverse transcriptase to conﬁrm a removal of
genomic DNA. To calculate levels of FXN expression,
the delta Ct value was generated by subtraction of the
Ct value of GAPDH from the Ct value of either FXN
mRNA or four different region transcripts of each cell
line. Levels of FXN mRNA from each cell line were
normalized to the delta Ct of GM15851. For levels of
FXN pre-mRNA expression, each delta Ct value of four
different regions at the FXN gene was normalized to the
delta Ct value of the region upstream of the GAA repeat
from GM15851. All primers used in this study are listed in
Tables 1 and 2.
Chromatin immunoprecipitation
Chromatin immunoprecipitation (ChIP) was performed
according to the EZ ChIP instructions (Upstate
Biotechnology Inc.). Brieﬂy, proteins and DNA we re
cross-linked with 1% formaldehyde for 10min (15min
for RNA pol II ChIP) at room temperature. The cross-
linking reaction was quenched with 125mM glycine for
5min (10min in the case of RNA pol II ChIP). Whole
lysates were prepared using a cell lysis buffer (50mM
Tris–HCl at pH8.0, 10mM EDTA and 1% SDS) supple-
mented with protease inhibitor (Mini EDTA-free protease
inhibitor cocktail, Roche) and sonicated to obtain 100–
300bp DNA fragments using a Bioruptor Sonicator
(Diagenode). The fragmented chromatin was diluted 10
times with dilution buffer (16.7mM Tris–HCl at pH 8.0,
167mM NaCl, 1.2mM EDTA, 1.1% Triton X-100 and
0.01% SDS). The chromatin fragments were pre-cleared
for 1h using Protein A agarose (Millipore) pre-blocked
with BSA and salmon sperm DNA. The equivalent of
5 10
6 (1 10
7 cells in the case of RNA pol II ChIP)
cells was immunoprecipitated overnight with 5mg of anti-
bodies recognizing histones and histone modiﬁcations
(15mg of RNA pol II antibody in the case of RNA pol
II ChIP). The immunoprecipitates were immobilized on
the pre-blocked protein A agarose beads for 1h.
Subsequently, the beads were washed with buffers con-
taining low salt, high salt, and LiCl. Chromatin was
eluted from the beads with elution buffer (100mM
NaHCO3 and 1% SDS) at room temperature for 15min
twice and subsequently subjected to the reverse cross-
linking reaction using 5M NaCl at 65 C for at least 5h.
The DNAs from chromatin complexes were isolated with
Tris–EDTA buffer (80mM Tris–HCl at pH 6.5 and
20mM EDTA) supplemented with Proteinase K and
RNase A at 37 C for 30min followed by 42 C for 1h.
DNA fragments were puriﬁed using phenol/chloroform
Table 2. Primers used for analyses in lymphoid cell lines
Primer (50–30)
Forward Reverse
Ex3/Ex4 CCTTGCAGACAAGCCATACA GGTCCACTGGATGGAGAAGA
In1Ex2 AGCACTCGGTTACAGGCACT GCCCAAAGTTCCAGATTTCC
 242 CGCATTTTATAAACAAGGCACA GTATGTGGGGCCAGGAGAC
Pro (or  133) CCCCACATACCCAACTGCTG GCCCGCCGCTTCTAAAATTC
+48 AAGCAGGCTCTCCATTTTTG CCGCAGGCACTCTTCTGT
Up (or +1231) GAAACCCAAAGAATGGCTGTG TTCCCTCCTCGTGAAACACC
+1394 GGTACGCCGCATGTATTAGG GCAACCAATCCCAAAGTTTC
Down CTGGAAAAATAGGCAAGTGTGG CAGGGGTGGAAGCCCAATAC
In2Ex3 GGTAATCATGTTTTGGGTTTTGTGC AGTCCTCAAACGTGTATGGCTTGTC
Number on the name of primers denotes the ﬁrst base of forward primer on the target region with respect to the TSS, +1.
Table 1. Primers used for analyses in the GFP_GAA system
Primer (50–30)
Forward Reverse
Repeat CTTCCCTTTACACAACGTTTGGGTT GTACTGTTTGGATTCAGTGAGGGACT
Ex1/Ex2 GCGACGTAAACGGCCACAAGTT ATGCCCTTCAGCTCGATGCGGT
Ex1/Int GACGACGGCAACTACAAGACC CTAGGACAAAGGTGCCTAAGACC
Up AATAGCCTCCTGACCACAGATCCTT CCATGTGACATCTAGCCCCGCA
Down CCCACAGGCCTGAAACACT TTCATGCGTGCTAGGGTAAA
Int/Ex2 CCCTAGCACGCATGAACC ATGCCCTTCAGCTCGATGCGGT
a
aThis primer is the same as the GFP Ex1/Ex2 reverse primer.
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qPCR was conducted using the Power SYBR Green-CT
Kit (7500 Fast Real Time-PCR System, Applied
Biosystems). The qPCR was carried out as follows:
10min at 94 C, 50 cycles of 30s at 94 C followed by
60s at 60 C. As changes in nucleosome occupancy occur
upon gene activation and gene silencing (15), it is note-
worthy that the relative abundance of histone modiﬁca-
tions (referred to as the ‘ratio’) determined by qPCR were
analyzed by normalizing the quantity of the immunopre-
cipitated sample to the quantity of total histone H3 (total
H4 in the case of H4K20me3) after normalization with
inputs.
Antibodies
The antibodies used in this study were: anti-rabbit IgG as
a negative control (Cell Signaling), anti-total H3 (Cell
Signaling or Active Motif), anti-total H4 (Abcam), anti-
H3K9/14ac (Upstate), anti-H3K4me2 (Active Motif),
anti-H3K4me3 (Abcam or Active Motif), anti-H3K9me3
(Upstate or Active Motif), anti-H3K27me3 (Abcam),
anti-H3K36me3 (Upstate), anti-H3K79me2 (Upstate or
Active Motif), anti-H4K20me3 (Active Motif) and an
antibody against the large subunit of RNA polymerase
II (N20; Santa Cruz Biotechnology).
Statistics
A two-way analysis of variance followed by the
Bonferroni post hoc test were performed to determine
the statistical signiﬁcance of the results of qRT–PCR
and ChIP analysis between unaffected and FRDA cell
lines.
RESULTS
Reduced level of the FXN pre-mRNA downstream of the
hyperexpanded GAA tract in FRDA cell lines
To conﬁrm FXN insufﬁciency in FRDA cell lines
(GM15850, GM16798 and GM16209), FXN mRNA ex-
pression was examined by qRT–PCR using a primer set
recognizing exon 3 as a forward primer and exon 4 as a
reverse primer (Figure 1B). The level of the FXN mRNA
expression varies signiﬁcantly among FRDA patients.
Affected individuals can express as little as 5% and as
much as 35% of FXN relative to a control individual
(16). In order to establish a common epigenetic proﬁle
of the FRDA individuals, we selected a representative
cohort of FRDA cell lines based on the expression of
the FXN mRNA. We selected cell lines expressing low
(GM16798) medium (GM15850) and high (GM16209)
levels of the FXN mRNA corresponding to  8, 17 and
29% of the amount of the FXN transcript found in the
GM15851 control cell line, respectively (Figure 1B).
In order to further determine the effect of the
hyperexpanded GAA repeats on the progression of tran-
scription throughout the FXN gene, we examined levels of
FXN pre-mRNA upstream (from+1231 to+1344 within
the intron 1) and in three regions downstream (variable
positions, depending on repeat tract length) of the GAA
repeats as schematized in Figure 1A. Importantly, all
A
BC
Figure 1. Decreased level of FXN pre-mRNA downstream of the hyperexpanded GAA repeats. (A) Schematic diagram of the FXN gene. Black lines
under the schematic diagram indicate regions ampliﬁed by designated primers used in this study. (B) FXN mRNA was analyzed in three control and
three FRDA cell lines by qRT–PCR with primers complementary to the exons 3 and 4. Blue-series bars designate control cell lines, while Red-series
bars designate FRDA cell lines. FXN expression was normalized to the expression level determined by control GM15851 cells. The experiment was
conducted in triplicate. All data are expressed as mean±SD. (C) Relative level of the FXN pre-mRNA was determined in various regions of the
transcript. ‘Up’ and ‘Down’ primers amplify regions in the immediate vicinity of the GAA repeats. In1Ex2 and In2Ex3 anneal to the junctions
between the corresponding introns and exons of the FXN pre-mRNA. The FXN pre-mRNA expression was normalized to the level of the fragment
ampliﬁed upstream of the GAA region in the control GM15851 cells. The experiment was performed in triplicate.
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pre-mRNA to avoid a bias from ampliﬁcation of mature
FXN transcript.
The qRT–PCR analyses revealed similar levels of the
FXN pre-mRNA at the region upstream of the
hyperexpanded GAA repeats in all three unaffected
control cell lines and two of the three FRDA lymphoid
cell lines (Figure 1C). The GM16798 FRDA cell line that
exhibited a lower level of the FXN pre-mRNA upstream
of the GAA repeats, as compared to the remaining ﬁve cell
lines, also exhibited the lowest level of mature FXN RNA.
In contrast to the similar levels of FXN pre-mRNA
upstream of the GAA triplet repeats, levels of FXN
pre-mRNA were reduced  4-fold at regions downstream
of the repeats in all three FRDA lymphoid cell lines
relative to unaffected cell lines.
We also conducted analyses of antisense transcription in
the FXN locus using strand-speciﬁc RT–PCR to evaluate
the relative contribution of sense and antisense transcripts
from the FXN locus. In agreement with previous data (11),
we were unable to detect antisense transcripts at the
regions speciﬁed in Figure 1A, either upstream or down-
stream of the GAA repeats (data not shown). Thus, all
FXN transcripts measured in our analysis reﬂect sense
RNA transcribed in the vicinity of the GAA tract. These
results strongly suggest that the GAA repeats affect later
steps of the transcription process that are downstream of
initiation.
RNA pol II distribution is inﬂuenced in the region
upstream of the GAA repeats but not at the promoter in
FRDA cell lines
In an effort to further understand how the hyperexpanded
tract of GAA repeats affects progression of FXN tran-
scription, we analyzed the distribution of total RNA pol
II at the FXN gene by ChIP assay using an antibody that
recognizes both phosphorylated and unphosphorylated
forms of the large subunit of RNA pol II (Figure 2).
We used seven primer sets to assure the ﬁne mapping
of the distribution of RNA Pol II in the FXN gene.
Based on prior studies demonstrating transcriptional
pausing at the long GAA tracts in vitro, as well as in
cell-culture systems (17,18), we expected that RNA pol
II progression would be impeded in the region upstream
of the hyperexpanded GAA repeats in FRDA cell
lines, which would result in the accumulation of transcrip-
tional machinery at the region upstream of the GAA
repeats. However, we observed decreased levels of RNA
pol II across the entire coding region of the FXN gene in
FRDA cell lines compared to unaffected cell lines.
Importantly, levels of RNA pol II were not changed
in the FXN promoter region (from  242 to  12) in
FRDA cell lines compared to control cell lines, suggest-
ing that FXN promoter activity is not affected in FRDA
cell lines. These results are in agreement with previ-
ous ﬁndings that similar levels of FXN pre-mRNA
at the region upstream of the GAA repeats are observed
in both FRDA and unaffected control cell lines
(Figure 1C).
Interestingly, RNA pol II accumulated at a
promoter-proximal region (from+48 to+150) in unaffect-
ed cell lines. This was an unexpected ﬁnding as the length
of the GAA repeats in these cells are short, ranging from 7
to 20 repeats. The accumulation of total RNA pol II at the
FXN promoter-proximal region is similar to what is
observed in several other genes (19), where RNA pol II
is known to pause. Pausing of RNA pol II was not
detected in the FXN promoter-proximal region of the
FRDA cell lines.
Collectively, these results suggest that transcriptional
defects in FRDA cells begin at a post-initiation step of
FXN transcription, which leads to decreased occupancy
of the transcriptional machinery at the promoter-proximal
region, as well as throughout the FXN gene.
Figure 2. Distribution of RNA polymerase II is affected in the region upstream of GAA repeats in FRDA cells. Level of total RNA pol II was
determined by immunoprecipitating the large subunit of RNA pol II in FRDA and control cells. Average occupancy of RNA pol II across the FXN
gene in all three FRDA and all three control cells is shown using red and blue dots, respectively. The position of the ﬁrst nucleotide for the forward
primer relative to TSS is indicated below the X-axis. The speciﬁcity of RNA pol II antibody for ChIP was veriﬁed by RNA pol II pausing at the
+55bp of the GAPDH gene. Error bars represent standard error of the mean. The experiment was conducted in triplicate using three FRDA and
three control cell lines. The P-value was generated by comparing the average percentage of input of total RNA pol II between unaffected and FRDA
lymphoid cell lines.
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region immediately upstream of the GAA repeats
in FRDA cell lines
We next examined distributions of H3K4me2 and
H3K4me3 at the FXN gene, as these marks at the
promoter are reﬂective of the transcriptional activity of
a gene. Although FXN mRNA levels are known to vary
considerably among FRDA individuals and unaffected
controls (20), the majority of studies to date have used a
single unaffected individual as a control to compare chro-
matin modiﬁcation changes at the FXN gene in FRDA
patients (10,21). Here, we analyzed cells from three un-
affected controls and three FRDA patients to delineate
consistent and signiﬁcant changes in chromatin structure
associated with the hyperexpanded GAA repeats in the
lymphoid cell lines.
Although variations in H3K4me2 and H3K4me3 levels
were observed within compared groups of cell lines, levels
of these histone marks were not different at the promoter
region (from  133 to  12) of the FXN gene in FRDA
cell lines and unaffected controls (Figure 3, upper panels).
These results are consistent with our quantitative pre-
mRNA analyses showing that the region upstream of
the GAA repeats is transcribed at the same level in both
unaffected and FRDA cell lines. Interestingly, in all three
FRDA cell lines levels of H3K4me2 and H3K4me3 were
signiﬁcantly lower at a region immediately upstream of
the GAA repeats (from +1231 to +1344). In contrast,
enrichment of H3K4me2 and H3K4me3 levels were the
highest at this region in the unaffected cells, which
correlated with the distribution of total RNA pol II at
the FXN gene (Figure 2). Levels of H3K4me2 have been
correlated with non-methylated CpG residues more tightly
than with transcriptional activity (22,23). Indeed, high
levels of DNA methylation have been reported in the
region upstream of the GAA repeats in FRDA cell lines
(24,25). Therefore, the decreased levels of H3K4me2 in
FRDA cell lines could reﬂect increased DNA methylation
speciﬁcally at this region. Previous reports have shown
that levels of H3K4me3 in coding regions are associated
with the efﬁciency of the post-initiation processes during
active transcription (26). The low levels of H3K4me3 in
FRDA cell imply that the hyperexpanded GAA repeats
affect the transition between initiation and elongation of
FXN transcription. Taken together, these results suggest
that the tract of hyperexpanded GAA repeats do not
affect chromatin structures at the FXN promoter region,
but do affect levels of H3K4me2 and H3K4me3 in the
vicinity of the GAA repeats, which indicates a defect-
ive transition between initiation and elongation of FXN
transcription in FRDA.
Decreased methylation levels of H3K36 and H3K79 in
FRDA cell lines
To further understand how the hyperexpanded GAA
repeats affect the transcription process throughout the
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Figure 3. Transcription associated histone modiﬁcations are reduced in FRDA cell lines compared to unaffected controls. Transcription status at the
FXN gene was determined by the distribution of histone modiﬁcations using the ChIP assay. DNA from chromatin immunoprecipitated using
antibodies speciﬁc for the indicated histone modiﬁcations was subjected to qPCR using primers amplifying promoter region, fragments upstream
(Up) and downstream (Down) of the GAA repeats and junction between intron 2 and exon 3 (In2Ex3). The experiment was conducted in triplicate
using three FRDA and three control cell lines. Data are expressed as mean±SEM. P-values were calculated by comparing the averages of the ratios
between unaffected and FRDA lines. For all histone modiﬁcation analyses shown in Figures 3–6, ChIP data are presented relative to input DNA and
normalized to the total H3 (or H4 in the case of H4K20me3) in each region.
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H3K79me2, which are characteristic markers of transcrip-
tion elongation. In unaffected controls, the level of
H3K36me3 gradually increased toward the 30-end of the
FXN gene, consistent with normal RNA pol II progres-
sion as shown in Figure 2. However, the level of
H3K36me3 was reduced across the entire FXN gene in
FRDA cell lines, indicating defective transcription elong-
ation in FRDA cell lines.
Recently, a genome-wide study revealed that full-length
transcription is often characterized by co-enrichment of
both H3K4me3 and H3K79me2 at regions downstream
of the TSS (27). In contrast, enrichment of H3K4me3
alone is characteristic of genes that undergo transcription
initiation, but not elongation (28). We found high levels of
H3K79me2 in regions upstream and downstream of the
GAA repeats in the unaffected control cells, whereas levels
of H3K79me2 were signiﬁcantly decreased throughout the
entire FXN gene in FRDA cells (Figure 3, bottom panel).
Because levels of H3K4me3 were unchanged at the FXN
promoter in FRDA cell lines (Figure 3, upper panel), these
results support the initial observation (Figure 1) that
FXN transcription is hampered at an elongation step
after successful initiation.
Enriched H3K9 methylation is accompanied by increase
of H3K27 and H4K20 methylation at the FXN gene
harboring the hyperexpanded GAA repeats
Other groups have reported decreased histone acetyl-
ation and increased methylation of H3K9 in the regions
ﬂanking the hyperexpanded tract of GAA repeats in
FRDA cells, patient autopsy tissues and mouse FRDA
models (7,10,11,21,24). We conﬁrmed that the levels
of H3K9/14ac were signiﬁcantly decreased at the FXN
gene, speciﬁcally at the region upstream of the GAA
repeats, in FRDA cells when compared with unaffected
cells (Figure 4, upper panel). In contrast to previous ﬁnd-
ings, in the promoter region of the FXN gene, the levels
of H3K9/14ac were similar in both groups. Consistent
with the results of H3K4me3, RNA Pol II and FXN
pre-mRNA expression analyses, these data indicate that
the hyperexpanded GAA repeats do not inﬂuence
promoter activity.
We also conﬁrmed that H3K9me3 was greatly enriched
in the region upstream of the GAA repeats in FRDA cell
lines (Figure 4, upper panels). Although the majority of
H3K9me3 is associated with repressed and silenced
regions throughout the genome, this histone modiﬁcation
is also found in the coding regions of transcriptionally
active genes (29). In centromeric heterochromatin, where
gene expression is repressed, enrichment of H4K20me3 is
accompanied by enrichment of H3K9me3 (30,31). To as-
certain whether high levels of H3K9me at the FXN gene
represent a heterochromatin-like structure adopted by
regions surrounding the hyperexpanded GAA repeats,
we determined the status of H4K20me3 at the FXN gene
in FRDA and control cell lines (Figure 4, bottom panel).
ChIP experiments showed that enrichment of H3K9me3
was also associated with signiﬁcant enrichment of
H4K20me3 at the region upstream of the hyperexpanded
GAA repeats in FRDA cells. These data further demon-
strate that the region immediately upstream of the
hyperexpanded GAA repeats adopts a heterochromatin-
like conformation in FRDA cell lines.
Figure 4. The region upstream of the GAA repeats in FRDA cells is enriched with histone modiﬁcations associated with repressive chromatin
structure. Chromatin structure at the FXN gene was deﬁned by ChIP using antibodies speciﬁc to the histone modiﬁcations indicated in each graph.
The experiment was conducted in triplicate using three FRDA and three control cell lines. Data are expressed as mean±SEM.
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chromosome and silenced inducible genes, are frequently
associated with enrichment of H3K27me3 (32,33).
Mapping of H3K27me3 in the FXN gene revealed an
over representation in the region upstream of the GAA
repeats in FRDA cell lines, co-localizing with H3K9me3
and H4K20me3 enrichments. Taken together, our data
indicate that the hyperexpanded tract of GAA repeats in
the FXN gene is associated with a unique constellation of
repressive histone modiﬁcations that lead to the formation
of a heterochromatin-like conformation.
Heterochromatin-like structure associated with the
hyperexpanded GAA repeats is formed in the
absence of transcription
To investigate whether the alteration of histone modiﬁca-
tions at the FXN gene result from inherent characteristics
of the FXN gene or from the hyperexpanded GAA
repeats, we employed a GFP_GAA reporter system that
harbors a single copy of the GFP reporter gene containing
560 or 0 GAA repeats in the intron as previously described
(9). The GFP_GAA system was established by inserting a
hyperexpanded tract of GAA repeats, derived from a
FRDA cell line, into the intron of a GFP reporter gene.
GFP transcription, driven by a CMV promoter, is
controlled by tetracycline repressor/operator. The
GFP_(GAA·TTC)560 and GFP_(GAA·TTC)0 cells
mimic FRDA and unaffected control cells, respectively.
Increased length of the GAA tract up to 560 repeats
leads to 2-fold decrease in the expression of the GFP
reporter gene (9). To assess changes in chromatin caused
by the insertion of long GAA repeats in the context of the
GFP gene, we analyzed the status of histone modiﬁcations
in the vicinity of the GAA repeats in the GFP_GAA
system (Figure 5). We conﬁrmed lower levels of H3K9/
14ac and high levels of H3K9me3 in the proximity of the
GAA repeats in GFP_(GAA·TTC)560 cells as previously
demonstrated (9). We found that both H3K9/14ac and
H3K9me3 enrichment extended up to the junction
between exon 1 and the intron as well as the intron and
exon 2 of the GFP gene in the GFP_(GAA·TTC)560 cells.
Next, we examined levels of H3K4me3 and H3K79me2 at
the GFP gene. No signiﬁcant changes in the levels of
H3K4me3 were detected at the junction between exon 1
and intron as well as in the region upstream of the repeats
in the GFP_(GAA·TTC)560 cells relative to the construct
lacking the GAA repeats. Levels of H3K4me3 were
reduced in the region downstream of the GAA repeats
in the GFP_(GAA·TTC)560 cells. This distribution of
H3K4me3 is similar to that found at the FXN gene in
the FRDA cell lines. Additionally, we found that
H3K79me2 was dramatically reduced at the region down-
stream of the GAA repeats in the GFP_(GAA·TTC)560
cells when compared to the corresponding region in the
GFP_(GAA·TTC)0 cells, indicating an impediment of
transcription elongation. These results clearly demonstrate
that the hyperexpanded GAA repeats not only induce epi-
genetic changes in the surrounding chromatin independent
of the DNA context, but also are sufﬁcient to inhibit tran-
scription elongation. Moreover, the landscape of histone
modiﬁcations in the GFP_(GAA·TTC)560 cells is similar
to that observed in FRDA cell lines. These facts strongly
suggest that elongation, but not initiation, is the major
step affected by the hyperexpanded GAA repeats in
FRDA patients.
Figure 5. Long GAA repeats induce repressive chromatin conform-
ation in the GFP reporter gene. The levels of histone modiﬁcations in
the GFP_GAA reporter system, schematically shown in the top panel,
were determined by ChIP assay. The black box represents CMV
promoter; the white box designates tetracycline operator that allows
regulating transcription initiation by tetracycline. The black lines cor-
respond to the location of the PCR products ampliﬁed following ChIP.
White bars represent the GFP_(GAA·TTC)0 cells. Gray bars represent
the GFP_(GAA·TTC)560 cells. Ex1/Int, junction between exon 1 and
intron; Up, region upstream of the GAA repeats; Down, region down-
stream of the GAA repeats; Int1/Ex2, junction between intron and
exon2. Data are expressed as mean±SEM. Asterisk indicates statis-
tical signiﬁcance (one: P<0.05, two: P<0.01, three: P<0.001). The
abundance of histone modiﬁcations is shown relative to input DNA in
the PCR and normalized to a total H3 for each region.
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the progression of RNA polymerases in vitro and in vivo
(17,18). Moreover, transcription arrest is associated with
changes in posttranslational histone modiﬁcations
(34–36). To determine if RNA pol II arrest can trig-
ger the cascade of silencing events, we used the
GFP_GAA system to precisely control initiation of tran-
scription using a tetracycline-regulated operator/repressor
(Figure 6). We used GFP_(GAA·TTC)560 and
GFP_(GAA·TTC)0 cells that were sub-cultured for less
than 10 passages prior to the experiment and had never
been maintained in the presence of tetracycline. Prior to
ChIP analyses the cells were cultured in parallel in the
presence or absence of the tetracycline. Upon the inhib-
ition of transcription, the levels of H3K9me3 were
enriched in the regions ﬂanking the GAA repeats in the
GFP_(GAA·TTC)560 cells. After induction of transcrip-
tion by the tetracycline, levels of H3K9me3 were un-
changed in the vicinity of the GAA repeats in the
GFP_(GAA·TTC)560 cells, as compared to the non-
tetracycline treated cells. However, levels of H3K79me2
were signiﬁcantly decreased at the region downstream of
the GAA repeats in the GFP_(GAA·TTC)560 cells upon
tetracycline treatment when compared to the cells cul-
tured in the absence of the tetracycline. These results
strongly suggest that the hyperexpanded GAA repeats
are the underlying cause for the formation of the
heterochromatin-like structure. The arrest of RNA pol
II is unlikely to serve as a signal instigating epigenetic
changes associated with long GAA repeats. Taken
together, our results demonstrate that FXN deﬁciency in
FRDA patients is a consequence of defective transcription
elongation through the heterochromatin-like structure
induced by the hyperexpanded GAA repeats.
DISCUSSION
In this study we demonstrated that the heterochromatin-
like structure induced by the hyperexpanded GAA repeats
leads to the inhibition of transcription elongation.
Moreover, this phenomenon is independent of the
sequence context of the hyperexpanded GAA repeats.
The shift in histone modiﬁcation patterns induced by
GAA repeats is locally restricted to the regions upstream
of the hyperexpanded GAA repeats at the FXN gene in
FRDA cells and does not extend to the promoter region.
Consequently, similar levels of the FXN pre-mRNA were
detected upstream of the GAA repeats in FRDA and un-
affected cell lines. On the contrary, a dramatic decrease of
the FXN pre-mRNA was observed at the region down-
stream of the hyperexpanded GAA repeats, indicating
an impediment of FXN transcription elongation in
FRDA cell lines. These results are corroborated by differ-
ences in the histone modiﬁcations as well as RNA pol II
occupancy throughout the FXN gene in FRDA cell lines.
Similar to the mutated FXN gene in FRDA cells, intro-
duction of the longer GAA repeats into a reporter gene
results in formation of heterochromatin-like conformation
and silencing of the transgene. The changes in the chro-
matin conformation triggered by the hyperexpanded GAA
repeats are independent of transcription, indicating that
the hyperexpanded GAA repeat tract is the primary
inducer of the heterochromatin-like structures that subse-
quently inhibit the transcription process.
Comparison of histone modiﬁcations and RNA pol II
distribution at the FXN gene between control and FRDA
cell lines provides a strong indication that FXN deﬁ-
ciency in FRDA cell lines originates at a post-initiation
step of transcription. Several reports using genome-wide
A
B
Figure 6. The tract of GAA repeats is sufﬁcient to form the
heterochromatin-like structure in the absence of transcription. (A)
The expression of GFP mRNA was analyzed in the absence/presence
of tetracycline using qRT–PCR. White bars represent results obtained
from cell line lacking the GAA repeats in intron of the GFP gene while
gray bars representing cells harboring intronic 560 GAAs. Data are
expressed as mean±SEM. The experiment was conducted in triplicate
and P-values were calculated from the average of all three determin-
ations for the GFP_(GAA·TTC)560 and the GFP_(GAA·TTC)0 cells.
(B) Effect of transcription on the formation of the heterochromatin-like
structure was analyzed using ChIP assay in the GFP_GAA system.
Enrichment of histone modiﬁcation at the region upstream (Up) and
the region downstream (Down) were determined in the absence and
presence of tetracycline (0.1mg/ml for 24h).
8374 Nucleic Acids Research, 2011,Vol.39, No. 19approaches have suggested that post-initiation events are
rate-limiting in the regulation of transcription (19,37).
This phenomenon was ﬁrst described for a heat shock—
inducible gene, Hsp70, in Drosophila (38). High levels of
RNA pol II were detected at the promoter of the
uninduced Hsp70 gene. The paused RNA pol II was
released by heat shock stimuli, which resulted in activation
of Hsp70 transcription (38). The increased level of RNA
pol II in the promoter-proximal region correlates with the
enrichment of active chromatin marks such as H3K9/14ac
and H3K4me3 at pause sites in the human genome (19). In
our analyses, pausing of RNA pol II at the promoter-
proximal region could be readily detected in control cell
lines, suggesting that this is part of physiological regula-
tion of the FXN gene expression. Although the occupancy
of RNA pol II at the promoter region is similar in un-
affected and FRDA cell lines, pausing of RNA pol II is
absent at the promoter-proximal region in the FXN gene
containing the hyperexpanded GAAs. Pausing of RNA
pol II may facilitate remodeling of the chromatin, as
shown in our results, to stimulate further transcription
progression, as well as stabilizing the binding of transcrip-
tion machinery facilitating subsequent rounds of tran-
scription initiation. Indeed, new FXN mRNA is slowly
synthesized in FRDA cell lines compared to unaffected
cell lines (21). The depleted RNA pol II in the coding
region of the genes is associated with low levels of
H3K4me2, H3K4me3, hyper-methylated DNAs at CpG
residues, and hyper-methylated histone H3 at lysine 9
(22,23). As expected, we detected low levels of total
RNA pol II in the region upstream of the GAA repeats
in FRDA cells. Moreover, the region immediately
upstream of the GAA repeats exhibits low levels of
H3K4me3 and H3K4me2 in FRDA cells as compared to
unaffected cells. H3K4me3 in the coding region is
associated with the efﬁciency of the post-initiation step
in transcription (22,23) and acts as an anchor to recruit
chromatin-modifying complexes (26,39). Thus, the signiﬁ-
cant decrease of H3K4me3 at the region upstream of the
GAA repeats in FRDA cells may impair the recruitment
of chromatin-modifying complexes that are necessary to
produce full-length transcripts, which subsequently results
in the impediment of FXN transcription elongation in
FRDA patients.
Regulatory elements located in the ﬁrst intron effect
expression of several genes (40,41). Studies using reporter
constructs have demonstrated that deletions of fragments
of the FXN intron 1 signiﬁcantly decrease luciferase
activity (24). Results of our ChIP experiments show the
most pronounced difference in the chromatin landscape
between FRDA and control cell lines exists in the intronic
region upstream of the hyperexpanded GAA repeats. This
region is also preferentially hyper-methylated in FRDA
patients (24) and the levels of DNA methylation correl-
ate with the number of the GAA repeats (25). One of
the methylated CpG residues at the region upstream of
the GAA repeats is embedded in an E-box motif
(CANNTG) that is recognized by bHLH transcription
factors. Analyses of global distribution of the c-Myc, the
bHLH transcription factor, demonstrated that this protein
interacts with the E-box located in the region upstream of
the GAA repeats (42). Moreover, the induction of c-Myc
has been shown to upregulate FXN transcription (43).
Myc proteins have been demonstrated to stimulate gene
expression via release of the paused RNA pol II (28) or by
interaction with histone modifying proteins such as
histone acetyltransferases (44,45). In contrast to FRDA
cells, the region upstream of the GAA repeats encompass-
ing the E-box motif in unaffected cells is enriched in
H3K4me3, H3K4me2 and H3K79me2 histone modiﬁca-
tions, potentially facilitating the binding of myc proteins.
Hypermethylated intronic regions (including the E-box
CpG) in FRDA patient cells, perhaps affect the inter-
actions between the E-box sequence and myc proteins
(46,47). Taken together these data emphasize the import-
ance of the region upstream of the repeats as the regula-
tory element of FXN expression. It is likely that long GAA
repeats induced epigenetic changes in the ﬁrst intron of the
FXN gene and interfere with transcriptional enhancers
leading to the reduced progression of transcriptional ma-
chinery and consequently to the silencing of FXN expres-
sion in FRDA.
Histone methylation status represents both an import-
ant regulatory element of gene expression and an indicator
of the transcriptional status of a gene. Enzymes that add
or remove methyl groups on speciﬁc sites of histones
regulate the balance between methylation and demethyla-
tion in the cell. The activity of a large group of histone
demethylases containing the Jumonji C-terminal domain
is dependent on the presence of non-heme iron (48).
Several reports demonstrate that low expression of
FXN, an iron chaperon, results in the accumulation of
iron in the mitochondria and the depletion of iron in
other cellular compartments leading to a severe imbalance
of iron in FRDA cells (2,3). This suggests that the con-
centration of iron is associated with the activity of an
iron-dependent demethylase in FRDA patients. In the
FRDA cells when compared to controls, we detected sig-
niﬁcant changes in various histone methylation marks
including H3K27me3 that can potentially be affected by
iron-dependent histone demethylases. In fact, overexpres-
sion of iron dependent UTX demethylase is responsible
for H3K27me3 demethylation and has been demonstrated
to increase expression of FXN mRNA in KYSE180
cancer cells (49). Additionally, FXN deﬁciency has been
shown to downregulate expression of genes involved in
DNA packaging and nucleosome assembly (50).
Although, expansion of the GAA repeats is the primary
factor driving chromatin changes, it is possible that meta-
bolic changes resulting from FXN deﬁciency in FRDA
cells contribute to the epigenetic landscape at the FXN
gene. Global analyses of nucleosome position and
histone modiﬁcations in FRDA are necessary to reveal
the full spectrum of epigenetic consequences attributed
to reduced FXN levels.
Dissecting the mechanism of transcriptional silencing
induced by the hyperexpanded GAA repeats is crucial
for the rational design of therapeutic strategies aimed to
alleviate transcriptional blocks imposed by the repeat ex-
pansions. Currently, the most promising small molecules
enhancing transcription of the FXN gene are HDAC in-
hibitors. HDAC inhibitors target the epigenetic
Nucleic Acids Research, 2011,Vol.39, No. 19 8375consequences of the GAA expansions and alter the chro-
matin status in the vicinity of the repeat tract without
affecting the chromatin landscape at the promoter
region of the FXN gene (10). However, the initial event
or signal instigating the cascade of epigenetic changes in
the GAA repeat region remains an open question. Perhaps
the hyperexpanded GAA sequences or non-canonical
DNA structures transiently formed by the hyperexpanded
GAA tracts recruit speciﬁc proteins that initiate modiﬁca-
tions in the chromatin environment surrounding the
repeats. Additionally, antisense transcription at the FXN
locus (FAST-1) can be involved in triggering silencing of
the FXN locus (11). Solving these questions will bring us
signiﬁcantly closer to developing an effective treatment for
FRDA and other diseases associated with repeat expan-
sion and gene silencing.
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